Baird lifts Axon stock target, keeps outperform rating on growth potential

Tomas Kauer - Moderator

Sep 10, 2024 - 22:00

Baird lifts Axon stock target, keeps outperform rating on growth potential

Tags:

Previous Article

CEL-SCI to Present New Data for Multikine ® Head & Neck Cancer Immunotherapy at ...

Majority of NGOs in Georgia refuse to register as 'foreign agents' under new law

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

FBRX stock touches 52-week low at $6.9 amid market challenges

FBRX stock touches 52-week low at $6.9 amid market chal...

Tomas Kauer - Mode... Sep 12, 2024

Australia's Domino's served with class action on 'misleading' Japan market comments

Australia's Domino's served with class action on 'misle...

Tomas Kauer - Mode... Sep 9, 2024

Workday acquires AI-powered document platform Evisort

Workday acquires AI-powered document platform Evisort

Tomas Kauer - Mode... Sep 17, 2024